Latest Breaking News On - Tri specific killer engager - Page 2 : comparemela.com

GT Biopharma, Inc (NASDAQ:GTBP) Sees Large Increase in Short Interest

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 102,200 shares, a growth of 122.2% from the September 15th total of 46,000 shares. Based on an average daily trading volume, of 265,000 shares, the short-interest […]

Atria wealth solutions incRenaissance technologiesGt biopharma incWells fargo companyGet free reportWealth solutionsStreet groupTrading downTri specific killer engagerGt biopharmaNasdaq gtbp

GT Biopharma (NASDAQ:GTBP) Trading Down 5 4%

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report)’s share price dropped 5.4% during trading on Wednesday . The company traded as low as $0.29 and last traded at $0.30. Approximately 109,688 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 303,826 shares. The stock had previously closed at […]

Wells fargo companyGt biopharma incRenaissance technologiesAtria wealth solutions incGt biopharma company profileGet free reportWealth solutionsStreet groupTri specific killer engagerGt biopharmaNasdaq gtbp

GT Biopharma, Inc (NASDAQ:GTBP) Short Interest Update

GT Biopharma, Inc (NASDAQ:GTBP) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Millennium managementAtria wealth solutions incGt biopharma incGet free reportWealth solutionsStreet corpJane street groupTrading downTri specific killer engager

GT Biopharma, Inc (NASDAQ:GTBP) Sees Large Decline in Short Interest

GT Biopharma, Inc. (NASDAQ:GTBP – Get Free Report) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totalling 185,600 shares, a drop of 15.6% from the July 15th total of 219,900 shares. Approximately 0.5% of the shares of the stock are sold short. Based […]

Armistice capitalGt biopharma incAtria wealth solutions incMillennium managementGet free reportWealth solutionsStreet corpTri specific killer engagerGt biopharmaNasdaq gtbp

HC Wainwright Reiterates Buy Rating for GT Biopharma (NASDAQ:GTBP)

GT Biopharma (NASDAQ:GTBP – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report issued on Tuesday, Benzinga reports. They currently have a $5.00 price target on the stock. HC Wainwright also issued estimates for GT Biopharma’s Q3 2023 earnings at ($0.10) EPS, Q4 2023 earnings at […]

Gt biopharma incArmistice capitalGt biopharma company profileRenaissance technologiesWells fargo companyGet free reportMontreal canStreet groupTri specific killer engagerGt biopharmaNasdaq gtbpReiterated ratingHc wainwright